< Back to latest news & events

Event

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

May 2021

Event date: 9th June 2021

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June.

In this webinar we will explore considerations for implementing an effective strategy to secure patent protection for personalised medical devices, and to steer through a potentially crowded competitive landscape, with a particular focus on comparing the European and US jurisdictions.

The emergence of new platform technologies directed to patient-specific healthcare solutions has led to significant investment and R&D associated with personalised medical devices. In order to protect their technological innovations, many companies are striving to strategically develop global patent portfolios that support the commercialisation of their products and which can leverage a dominant commercial position over competitors. As national and regional differences exist between legal provisions that govern intellectual property, it is not always possible to adopt a “one-size-fits-all” approach. A more thorough understanding of these differences is therefore vital when seeking to maximise the scope of protection available to the patent proprietor or to minimise patent infringement risk when commercialising personalised medical devices.

This webinar will cover:

  • an overview of the growth in patent applications for personalised medical devices and examples of patent claims that can protect them;
  • considerations for drafting and prosecuting patent applications directed to personalised medical devices and how these approaches differ between Europe and the US;
  • a case study examining litigation, in the US, of a patent portfolio with claims covering personalised medical devices and how defendants challenged patent validity.

Speakers

Dr Adam Hines, HGF

Christy Lea, Knobbe Martens

Sabing Lee, Knobbe Martens

Date

9th June

Time

4.00 pm (BST)

8.00 am (PT)

10.00 am (CT)

11.00 am (ET)

Attendees

Latest updates

PRESS RELEASE - HGF secures private equity investment.

HGF secures private equity investment to propel its vision of being Europe’s IP Firm of Choice; to  attract top talent and to deliver excellence to clients. Over the past 30 …

Read article

Managing IP Rising Stars 2024

We are delighted to announce that 12 of our esteemed attorneys have been listed in the 2024 Managing Intellectual Property (MIP) Rising Stars guide! This prestigious recognition highlights the best …

Read article
Event - 15th - 16th October 2024

LSPN North America Fall 2024

HGF are proud to be platinum sponsors of LSPN North America Fall 2024. This year’s event will be held in San Francisco on Tuesday 15th and Wednesday 16th of October …

Event details

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article

The Patent Lawyer: UPC’s first year: emergence of a purely civil law system?

The UPC passed its milestone 1 year anniversary on 1 June 2024. At the time of writing we are still awaiting the first substantive decisions on invalidity and infringement, there …

Read article

NK Cell Therapy – an IP update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medicine’s Agency approved the first …

Read article